ELF3 and prostate cancer: Through NF-κB, IL-1β induces the activation of epithelium-specific ETS (E26 transformation-specific) ESE1 (or E74-like factor (ELF3)), two ETS family members responsible for prostate cancer malignancy and associated with a poor prognosis for patients [100].